MedShape is an Atlanta‑based medical device company that develops and commercializes surgical solutions built on its patented shape memory polymer and metal alloy technologies. The company is led by CEO Kurt Jacobus. It intends to use proceeds from the financing for further development and commercialization of pipeline products, including the full market release of the Eclipse Soft Tissue Anchor. Eclipse is made from the company’s proprietary PEEK Altera® and features a non‑rotational deployment technique designed to better replicate native soft tissue anatomy and functionality. The device is available in 4–9 mm diameters and 10–20 mm lengths and accommodates numerous anatomies for tenodesis and tendon transfer procedures. Eclipse received FDA 510(k) clearance in March 2013 and has been under a controlled market release since August 2013, with use in procedures including a proximal biceps repair at Arizona Spine and Joint Hospital and various hand, knee, foot and ankle reconstructions. MedShape is a privately held medical device company headquartered in Atlanta, GA that develops orthopedic devices using proprietary shape memory technology. Its core product focus is on surgical solutions for sports medicine, joint fusion, and musculoskeletal trauma. The company is working to build and commercialize a portfolio of patented technologies and related surgical products. MedShape secured external financing to support its operations and growth initiatives. Management says the financing will provide flexibility to expand and help execute the company’s growth strategy. The company obtained a multi-draw facility to support general working capital needs. MedShape Solutions is an Atlanta, GA–based developer of orthopedic medical devices built from shape memory materials. Its technology platform comprises proprietary shape memory polymers and shape memory alloys designed to morph between two shapes in response to specific stimuli. MedShape applies these materials to improve fixation of soft tissue to bone and bone to bone, reduce the invasiveness and complexity of surgical techniques, and develop durable implants that adjust to changing conditions within the human body. The company’s products are positioned to simplify certain orthopedic procedures and improve implant performance through adaptive materials. MedShape announced a strategic investment from In-Q-Tel, which company leadership said could open opportunities to use its technology in support of the U.S. Intelligence Community.

Total raised

$14M

Funding rounds

3

Latest round

Equity

Latest activity

Oct 2013